MedTrace Logo

Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes

NCT02850224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 703

Last updated 2020-07-28

No results posted yet for this study

Summary

In 2012, an Expert Panel of the National Heart Lung and Blood Institute published guidelines on cardiovascular health and risk reduction in children; among these guidelines were screening recommendations for obesity and obesity-related conditions. Following publication of this report there was a call for caution and for increased patient (parent, child) input on implementing these guidelines. There are limited current studies evaluating patient-centered outcomes (PCO) in the well-child setting, however, given the childhood obesity epidemic, there is a clear need for such an evaluation. The city of Detroit, MI ranks first among 22 cities with data for the prevalence of overweight and obese youth (39.7%), making Henry Ford Health System, which is located in Detroit, MI, an ideal setting to study childhood obesity related research questions.

Conditions

Interventions

BEHAVIORAL

Motivational interviewing to elicit PCO in pediatrics

A motivational interviewing style webinar. Physicians watch the webinar, incorporate communication techniques.

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Andrea E Cassidy-Bushrow, PhD · Henry Ford Health System

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2018-02-19
Completion
2020-07-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02850224 on ClinicalTrials.gov